As tempting as discounted stocks may be, investors must remain cautious and assess each opportunity based on its long-term ...

We anticipate a 46% upside potential to fair value of $36.6. Read here for an analysis of Rocky Brands (RCKY) stock's Q3 ...

Alnylam Pharmaceuticals (NASDAQ:ALNY), with a market capitalization of $35.4 billion, has emerged as a leading player in the RNA interference (RNAi) therapeutics space, with a particular focus on ...

Operating income was $6.2 million in the first quarter of fiscal 2025, compared to $9.7 million in the prior year period. This led to net earnings in Q1 ’25 of $5.1 million, compared to $7.3 million ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Legacy Ingersoll Rand's climate segment was renamed Trane Technologies. We had long viewed legacy Ingersoll Rand's climate business as more attractive than its industrial segment because the former ...

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

Check out these helpful websites to boost small business growth. Access tools, resources, and expert advice to advance your ...

AI investors are desperately trying to find clues on the real impact of DeepSeek on chip demand in the future and gauge how ...

Growth stocks are one of the best assets to build wealth over the long term. If you carefully choose stocks of growing ...

Live Updates Deep Dive into ABBV's Earnings Call 11:53 am Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue ...

Novartis expects profit and sales to grow further this year after beating analysts’ expectations, boosted by revenue from its ...